Three stocks which you have missed – OPXA, CEP, REV

Northern, WI 02/06/2013 (wallstreetpr) – It was a day for stocks like Opexa therapeutics, Constellation energy partners and Revlon inc which gained most on the backdrop of news and positive sentiment.

  1. Opexa Therapeutics Inc (NASDAQ:OPXA): OPXA (Opexa Therapeutics Inc.) is a bio pharmaceutical company specialized in developing personalized cellular therapies for curing potential illness. The share of the company went up by as much as 211% during intraday and settled at $3.15 per share during closing with an increase of 160.33%. It was one of the most active stocks after it announced its agreement with Merck Serono, for development and marketing of Tcelna, a Tcell therapy to treat multiple sclerosis. Share price reached a new 52 week high. Company is set for its Q4 earnings call on February 21st 2013.
  2. Constellation Energy Partners LLC (NYSEARCA:CEP): Constellation Energy Partners LLC went up by 30.77% after news came in that the company is in talks for a acquisition, development and production of onshore oil and gas in United States. Earlier company had entered into an agreement to sell its Robinson’s Bend field to a subsidiary of Castleton commodities International LLC Which is expected to be completed by Q1, 2013.
  3. REV: (NYSE:REV): Revlon Inc shares closed at $18.13 a share on Tuesday with an increase of 18.31%. The largest beauty care product company posted a strong increase in sale of its makeup and hair color products. Net income for Q4 rose 28% compared to previous quarter, it also said that the interest rate for $500 Million worth notes was fixed at 5.75% which is due in 2021

Please make sure to read and completely understand our disclaimer at While reading this article one must assume that we may be compensated for posting this content on our website.

Published by Flavia Carruth

Hi, I am Flavia and have done my MBA with finance as specialization and a Bachelor in Economics with 4 years of experience as Financial Analyst in leading Software Firm. I have passion for article writing, report making and stock market Analysis.

Recent Stories

SignUp Now For Our Featured Newsletter